Cardiac disease is well known to be the leading cause
|
|
- Nicholas Wilkerson
- 6 years ago
- Views:
Transcription
1 Coronary Artery Bypass Grafting in Who Require Long-Term Dialysis Leena Khaitan, MD, Francis P. Sutter, DO, and Scott M. Goldman, MD Main Line Cardiothoracic Surgeons, Lankenau Hospital, Jefferson Health System, Wynnewood, Pennsylvania Background. Should coronary artery bypass grafting (CABG) be performed in patients on long-term dialysis? This subject has been debated for several years. We retrospectively reviewed the charts of all patients who had CABG from August 1989 to October Methods. We identified 70 patients who were on longterm dialysis and had CABG during that time period. were evaluated by chart review and telephone survey. Forty-nine patients (70%) had unstable angina and 37 patients (52%) had triple vessel disease. Patient risk factors included 60 patients with hypertension (85%), 40 patients with diabetes mellitus (57%), 35 patients who had congestive heart failure (50%), 35 patients who had a previous myocardial infarction (50%), and 31 smokers (44%). Operative procedures included 49 patients who had CABG only and 21 patients who had concomitant CABG with valve replacement or repair. During the postoperative period, complications developed in 50% of patients. Results. Review of these complications showed that 25% of patients required prolonged mechanical ventilation, and 10% of patients had septicemia. Operative mortality was high, with 10 patient deaths (14.3%) within 30 days of the procedure. Six (60%) of these deaths occurred in patients who had CABG and valve repair or replacement. Long-term follow up at 50.3 months showed no improvement in survival in patients who had CABG compared with the known mortality rate of 22% per year in dialysis patients regardless of comorbid conditions. Quality of life subjectively improved in only 41% of patients in follow-up telephone survey. Conclusions. requiring long-term dialysis with coexistent severe cardiac disease should be thoroughly evaluated preoperatively. One must weigh the high morbidity and mortality risk against the limited long-term resolution of angina and ultimate survival. (Ann Thorac Surg 2000;69:1135 9) 2000 by The Society of Thoracic Surgeons Cardiac disease is well known to be the leading cause of death in dialysis patients; it accounts for 47% of deaths in the dialysis-dependent patient population according to the latest renal database [1]. In this patient population cardiac death is higher because of the presence of hypertension, hyperlipidemia, and abnormal carbohydrate metabolism leading to accelerated atherosclerosis [2 4]. Coronary artery bypass grafting (CABG) has become the standard of care for dialysis patients with cardiac disease that is uncontrollable with medical therapy. This becomes increasingly important as more patients go on dialysis, and the dialysis population becomes older. There is a direct correlation between cardiac death and age in the dialysis population. In patients aged 20 to 64 years, cardiac disease accounts for a death rate of 85.3 per 1,000 patient years. In patients aged more than 65 years, cardiac disease accounts for a death rate of per 1,000 years [1]. The first CABG performed in a patient with chronic renal failure was in 1974 by Menzoin and associates [5]. Since then many case reports and retrospective reviews in small groups of patients have been published regarding the benefit and feasibility of CABG in this patient Accepted for publication Oct 2, Address reprint requests to Dr Sutter, Lankenau Hospital, Main Line Cardiothoracic Surgeons, Medical Science Building, Suite 280, 100 Lancaster Ave, Wynnewood, PA 19066; mlcts2220@aol.com. population. Some groups have shown improved survival and improved quality of life [6 9]. Other studies have shown the opposite [10 12]. And yet other studies have shown an improved quality of life but no improvement in survival [13 15]. Because most publications are in groups of 30 patients or fewer, one can make observations but no steadfast conclusions. Therefore CABG in the dialysis patient remains a debated issue. We reviewed our experience in 70 patients who are on long-term dialysis and had cardiac surgery. We studied subgroups that are at higher risk to determine whether CABG is efficacious in this patient population in terms of quality of life and patient survival. and Methods We retrospectively reviewed our ongoing Society of Thoracic Surgery database at The Lankenau Medical Center to identify patients who are on chronic dialysis and who had CABG between August 1, 1989, and October 31, Only patients who were already on dialysis at the time of surgery and dependent on dialysis were included. All patients who became dialysis dependent after CABG This article has been selected for the open discussion forum on the STS Web site: by The Society of Thoracic Surgeons /00/$20.00 Published by Elsevier Science Inc PII S (99)
2 1136 KHAITAN ET AL Ann Thorac Surg CABG IN DIALYSIS PATIENTS 2000;69: Table 1. Survey Questions 1. How did the surgery affect your quality of life in terms of your living situation? 11% of patients who were living independently now live in assisted living 5% of patients who were living independently now live in a nursing home 76% of patients living situation stayed the same 2. How long did it take you to recover from the operation? In all patients surveyed, it took approximately 2.2 months to recover, on average 3. Did your presenting symptoms improve after your heart surgery? 65% of patients said yes, the symptoms improved 24% of patients said no, the symptoms did not improve 11% of patients said they could not remember 4. Is your overall health the same/better/worse since surgery? And in what way? 14.8% of patients said their overall health status is the same 41% of patients said their overall health status is better 33% of patients said their health status is worse 5. How has the surgery affected your lifestyle? 13% of patients who were hospitalized infrequently before their cardiac surgery are now hospitalized frequently 26% of patients report fewer hospitalizations after their cardiac surgery 55% of patients report the frequency of hospitalizations to be unchanged 6. Have you had angina or shortness of breath since the surgery? If yes, how long after your procedure? 31% of patients reported cardiac symptoms after the procedure 68% had no recurrent cardiac symptoms after the procedure 7. Have you been admitted to the hospital since your CABG for cardiac disease? If yes, how long after your procedure? Have you been admitted more than once? Have you had any cardiac interventions since your CABG? 35% were admitted to the hospital since their operation for cardiac reasons 5% of patients have required a cardiac intervention since CABG were excluded from this study as were patients with chronic renal failure who were not on dialysis and patients with chronic renal insufficiency. Information was also obtained from patient chart review and by telephone survey. Telephone survey was conducted by two people. The patient or the closest living relative was interviewed. All were asked a standardized set of questions in an objective format. Telephone interview focused on questions regarding the patients quality of life with regards to their living situation (independent versus assisted), their overall health status since the operation, frequency of hospitalizations, and cardiac symptoms since CABG (Table 1). Data were analyzed using a 2 analysis, Fischer exact test, Wilcoxon analysis, Kaplan-Meier estimates, and a multivariable model. A series of univariable Cox proportional hazards models was used to identify significant predictors of survival. Kaplan-Meier survival curves were computed to compare patient groups and account for variable follow-up times. From August 1989 to October 1997, 7,200 patients had cardiac procedures at the Lankenau Hospital. Seventy patients were identified who fit inclusion criteria. There were 44 men and 26 women. Mean age was 62.5 years with a range of 37 to 83 years. At the time of CABG, 58 patients were on hemodialysis, and 12 patients were on peritoneal dialysis. All patients were followed by renal consultants throughout their hospitalization. Most patients had renal failure secondary to diabetes or hypertension. A high number of risk factors were noted in the population. Forty-nine patients (70%) had unstable angina, 40 patients (57%) had diabetes mellitus, 35 patients (50%) had congestive heart failure (CHF), and 35 patients (50%) had preoperative myocardial infarction (Table 2). All patients had CABG, but with 50 patients had CABG only and 20 patients had CABG with valve replacement or repair. Presenting symptoms included angina, shortness of breath, myocardial infarction, and syncope. The indication for the procedure in 67 patients was failure of medical therapy to treat cardiac disease. The other 3 patients had the procedure after they were noted to have significant cardiac disease during examination for renal transplantation. Another 5 patients who later had renal transplant were placed on the transplant list after their cardiac operation. Criteria for renal transplantation are based on the Patient Care and Education Committee of the American Society of Transplant Physicians [16]. Table 2. Patient Risk Factors Risk Factor Number of %of Hypertension Diabetes mellitus Congestive heart failure Smoker Peripheral vascular disease a Hypercholesterolemia Cerebrovascular disease Chronic obstructive pulmonary disease Preoperative myocardial infarction Triple vessel disease Unstable angina New York Heart Association class I II III IV Left main artery 50% a Peripheral vascular disease is defined as patients who have claudication or had a peripheral bypass procedure.
3 Ann Thorac Surg KHAITAN ET AL 2000;69: CABG IN DIALYSIS PATIENTS 1137 Table 3. Complications Table 4. Causes of Death Complication Number of %of Cause of Death Perioperative Death a Late Death Prolonged mechanical ventilation Atrial fibrillation Gastrointestinal complication a 8 11 Septicemia 7 10 Pneumonia 7 10 Reoperative bleeding 7 10 Transfusion requirement Cerebrovascular accident 6 8 Cardiac 5 11 Pulmonary 3 Sepsis 3 1 Renal failure 4 Malignancy 1 Multisystem organ failure 2 2 Unknown 5 a Death within 30 days of procedure. a Defined as bleeding or ileus postoperatively. Results Short-Term Follow-up Postoperatively, 50% of patients had complications, with an average of three complications per patient. The most severe complications were those of prolonged mechanical ventilation (18 patients, 26%), atrial fibrillation (15 patients, 21%), and gastrointestinal complications (8 patients, 11%). All 70 patients (100%) received perioperative transfusions (Table 2). Average hospital stay was 24 days per patient. There were no complications in the 8 patients who later had kidney transplant. Hospital death, defined as occurring within 30 days of operation, was high at 14.3% (10 patients). Five patients died of cardiac causes, 3 died of sepsis, and 2 patients died secondary to multisystem organ failure (Table 3). A higher mortality rate was also noted in the older patients, with seven of the 10 deaths (70%) occurring in patients older than 65 years. were also subgrouped into those who had CABG alone versus CABG with valve replacement or repair. Six of the hospital deaths occurred in the 20 patients who had concomitant valvular procedures (30%). Long-Term Follow-Up Mean follow-up time was 50.3 months in the total patient population. Only 6 patients were lost to follow-up. Of the remaining 64 patients, 37 are currently deceased. There were 27 late deaths. Twenty-seven patients are currently alive. Mean survival after CABG was 40 months. Mean time to death after CABG was 29 months (Fig 1). In the CABG and valve operation subgroup, mean survival was only 20.7 months. Mean time to death after CABG with valve replacement or repair was 15 months. The causes of late death included 11 patients who died of cardiac causes, 3 of pulmonary causes, and 2 patients of multisystem organ failure (Table 4). Four patients were listed as dying from renal failure. These patients opted to discharge themselves from dialysis secondary to other medical conditions and died of uremia. Eight patients later had renal transplants, and all are currently alive and doing well. Only 1 of the patients who went on to transplant had both CABG and valve repair. Three of these patients had the CABG in preparation for the renal transplant. The other 5 patients were considered to be transplant candidates after having their cardiac procedure. The criteria used for transplant are best defined by the American Society of Transplant Physicians [16]. Statistical analysis was done to identify the subgroup of patients who had worse outcomes after CABG. Risk factors that were considered included age, cardiomegaly, CHF, diabetes, and hypertension. In a univariable and multivariable model, the only risk factors that were noted to be statistically significant were CHF ( p 0.01) and cardiomegaly ( p 0.02) (Table 5). In Figure 1, the expected survival of dialysis patients after CABG is shown. Fifty percent of patients were dead at 38 months follow-up. with cardiomegaly have a risk of Table 5. Relative Risk Factor Comparison Between Alive Versus Dead Risk Factor Alive (n 27) Dead (n 37) p Value Fig 1. Kaplan-Meier Survival Estimates for all. Cardiomegaly Congestive heart failure Chronic obstructive pulmonary disease Subendocardial infarct Female gender Pulmonary hypertension
4 1138 KHAITAN ET AL Ann Thorac Surg CABG IN DIALYSIS PATIENTS 2000;69: mortality that is increased threefold compared with the other patients who had CABG (Fig 2). In patients with CHF, the relative risk was 3.75 (Fig 3). In Figures 2 and 3, it is evident that the patients with these risk factors are likely to die sooner after their CABG. Although the perioperative mortality rate was higher in patients older than 65 years, this was not an independent risk factor for long-term survival. A telephone survey was conducted to assess patient survival and satisfaction with the procedure. The 10 patients who died perioperatively (within 30 days of their procedure) and the 6 patients lost to follow-up were excluded. For the few patients who could not be located, additional information was obtained by chart review. Twenty-seven patients were contacted by telephone. At the time of telephone survey, 27 patients were deceased, and the closest living relative was interviewed. Most patients said that their living situation remained the same after the cardiac procedure. Sixty-five percent said their cardiac symptoms improved postoperatively, but only 41% said that their overall health status improved. This translates to 59% of patients feeling the same or worse after their procedure (Table 1). Fig 2. Kaplan-Meier Survival Estimates by Cardiomegaly. Fig 3. Kaplan-Meier Survival Estimates by Congestive Heart Failure. Comment In this study we present a large series of dialysisdependent patients who had CABG. It is known that these patients have worse outcomes than the usual patient who undergoes open heart operation, yet these patients continue to appear on the cardiothoracic surgeon s schedule. Many studies have been published reviewing small groups of patients with varying conclusions some report patients with longer survival, others show patients to have higher morbidity and mortality rates. It is difficult to compare all of these studies because the inclusion criteria are inconsistent. We have included only patients who were dialysis dependent and had CABG with or without valve replacement or repair. In the short term, these patients generally fared poorly. The perioperative mortality rate was 14.3% in this study, and these patients had many complications and prolonged hospital stays. In the subgroup that had concomitant valvular and cardiac revascularization, the perioperative mortality rate was 30%. In the nondialysis population at this institution, the perioperative mortality rate is 2% with hospital stays of 7 days or fewer. With the tremendous increase in morbidity, it is difficult to operate on these patients. The obvious next question is, what would happen to these patients in this time period if they were not revascularized. Unfortunately, the answer to this question is not known and it is difficult to obtain. Such a prospective randomized study cannot be done. At long-term follow-up, the mortality rate in this population was similar to that of the general dialysis population. The expected mortality rate for any dialysis patient is 22% per year [1]. In patients who had CABG at this institution, the mortality rate also was 22% per year. If one assumes that these patients would have died sooner without surgical intervention, then perhaps the patient s outcomes were improved by revascularization. Some of the interesting findings in this review include the subgroups identified as being at higher risk of death after CABG. with cardiomegaly and CHF had a mortality risk increased three to four times that of the remainder of the patients in this group. Also, patients with concomitant valve operations had a decreased survival compared with the CABG only patients. In the follow-up telephone survey, we found that 33% of patients thought that their health status deteriorated after the cardiac operation, and 15% of patients thought that their health status did not change. Although the questions are general and subjective, they were asked objectively, and patients responded honestly. When asked more specifically, 65% of patients stated that the symptom that led to their cardiac procedure improved. However, 35% felt their cardiac symptoms did not improve. Should cardiac surgeons continue to perform CABG in this group of patients? This is a difficult question to answer because at least 40% of patients do feel better in
5 Ann Thorac Surg KHAITAN ET AL 2000;69: CABG IN DIALYSIS PATIENTS 1139 the long term. However, the risk of death is high in dialysis-dependent patients who have CABG. The patient should be aware of this. If one assumes that these patients were so ill before their CABG and certainly would have not survived much longer, then CABG in this patient population may be justified. Operating on these patients could improve the final outcome. Again, without a prospective randomized study, this question cannot be answered. The patients who later have kidney transplant benefit greatly from their CABG. These patients comprise a different population. The conditions and performance status that must be met to qualify for transplantation are rigorous [16]. Most would not be able to have a transplant without a cardiac operation. Only 3 patients who had transplants in this series had their cardiac procedure as a result of findings during the preoperative transplant examination. The other 5 patients were placed on the list only after having their CABG. These transplant patients may be a slightly different patient population, as all have done well in our experience and had no major complications in the perioperative period. Such patients should have CABG if needed. For dialysis-dependent patients not in line for transplant but with medically uncontrollable cardiac disease, the question becomes more difficult. There has been no prospective randomized study to compare how patients with the same disease and no CABG fare. One casecontrolled study in a small group of patients found that the mortality rate is much higher in the dialysis patient compared with a nondialysis patient with the same cardiac profile [11]. That study would be more interesting if the control group was also dialysis dependent but did not have CABG. In our experience, survival is the same regardless of whether a patient on long-term dialysis has CABG. Additionally, patients with CHF and cardiomegaly have a greater risk of dying than even the average dialysis patient who has CABG. Based on these data, one cannot refuse to perform CABG in this patient population. However, the surgeon should inform the patient that less than half of patients feel better after operation and that the risk of complications and perioperative mortality is higher than that for the nondialysisdependent patient. Surgeons may want to avoid operating on patients with cardiomegaly, CHF, or those who also need valvular repair or replacement. In a dialysis-dependent patients with medically uncontrollable cardiac disease, surgeons should be aware of the high morbidity and mortality rates associated with CABG in this population. Only patients who cannot continue their current lifestyle secondary to their cardiac disease should have CABG. These patients should know that their cardiac symptoms improve 60% of the time but that less than half of these patients will report improved health status overall. Additionally, CABG will not improve the patient s long-term survival, and patients with CHF, cardiomegaly, or valve operations will have a worse outcome with an increased risk of death. References 1. United States Renal Data System, Bethesda Maryland: National Institutes of Health, Haire HM, Sherrard DJ, Scardapane D, Curtis FK, Brunzell JD. Smoking, hypertension and mortality in a maintenance dialysis population. Cardiovasc Med 1978;3: Bagdade JD. Uremic lipidemia, an unrecognized abnormality in triglyceride production and removal. Arch Intern Med 1970;126: Hampers CL, Lowrie EG, Soeldner JS, Merrill JP. The effect of uremia on glucose metabolism. Arch Intern Med 1970;126: Menzoin J, Davis RC, Idelson BA, et al. Coronary artery bypass surgery and renal transplantation: a case report. Ann Surg 1974;179: Blum U, Skupin M, Wagner R, Mathies G, et al. Early and long-term results of cardiac surgery in dialysis patients. J Cardiovasc Surg 1994;2: Batiuk TD, Kurtz SB, Oh JK, Orszulak TA. Coronary artery bypass operation in dialysis patients. Mayo Clin Proc 1991; 66: Rinehart AL, Herzog CA, Collins AJ, et al. A comparison for coronary angioplasty and coronary artery bypass grafting outcomes in chronic dialysis patients. Am J Kidney Dis 1995; 25: Francis GS, Sharma B, Collins AL, Helseth HK, et al. Coronary-artery surgery in patients with end-stage renal disease. Ann Intern Med 1980;92: Blakeman BM, Pifarre R, Sullivan HJ, et al. Cardiac surgery for chronic renal dialysis patients. Chest 1989;95: Deutsch E, Bernstein RC, Addonizio P, Kussmaul WG III. Coronary artery bypass surgery in patients on chronic hemodialysis. A case-control study. Ann Intern Med 1989;110: Samuels LE, Sharma S, Morris RJ, et al. Coronary artery bypass grafting in patients with chronic renal failure: a reappraisal. J Cardiac Surg 1996;11: Jahangiri M, Wright J, Edmondson S, Magee P. Coronary artery bypass graft surgery in dialysis patients. Heart 1997; 78: Owen CH, Cummings RG, Sell TL, et al. Coronary artery bypass grafting in patients with dialysis-dependent renal failure. Ann Thorac Surg 1994;58: Salem MM, Mujais S. Coronary revascularization in dialysis patients: the need for vigilance. Intl J Artif Organs 1991;14: Kasiske BL, Ravenscraft M, Ramos EL, et al. The evaluation of renal transplant candidates: clinical practice guidelines. Patient Care and Education Committee of the American Society of Transplant Physicians. J Am Soc Nephrol 1995;6: 1 34.
Does Coronary Artery Bypass Graft Surgery Improve Survival Among Patients With End-Stage Renal Disease?
Does Coronary Artery Bypass Graft Surgery Improve Survival Among Patients With End-Stage Renal Disease? Todd M. Dewey, MD, Morley A. Herbert, PhD, Syma L. Prince, RN, Carrie L. Robbins, RN, Christina M.
More informationAssessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington
Assessing Cardiac Risk in Noncardiac Surgery Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington Disclosure None. I have no conflicts of interest, financial or otherwise. CME
More informationPOOR LONG-TERM SURVIVAL AFTER ACUTE MYOCARDIAL INFARCTION AMONG PATIENTS ON LONG-TERM DIALYSIS
POOR LONG-TERM SURVIVAL AFTER ACUTE MYOCARDIAL INFARCTION AMONG PATIENTS ON LONG-TERM DIALYSIS CHARLES A. HERZOG, M.D., JENNIE Z. MA, PH.D., AND ALLAN J. COLLINS, M.D. ABSTRACT Background Cardiovascular
More informationThe MAIN-COMPARE Study
Long-Term Outcomes of Coronary Stent Implantation versus Bypass Surgery for the Treatment of Unprotected Left Main Coronary Artery Disease Revascularization for Unprotected Left MAIN Coronary Artery Stenosis:
More informationDoes Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement?
Original Article Does Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement? Hiroaki Sakamoto, MD, PhD, and Yasunori Watanabe, MD, PhD Background: Recently, some articles
More informationCost-effectiveness of minimally invasive coronary artery bypass surgery Arom K V, Emery R W, Flavin T F, Petersen R J
Cost-effectiveness of minimally invasive coronary artery bypass surgery Arom K V, Emery R W, Flavin T F, Petersen R J Record Status This is a critical abstract of an economic evaluation that meets the
More informationRisk Stratification Using The Society of Thoracic Surgeons Program
Risk Stratification Using The Society of Thoracic Surgeons Program Brack G. Hattler, MD, PhD, Carol Madia, PA, Carol Johnson, CRNP, John M. Armitage, MD, Robert L. Hardesty, MD, Robert L. Kormos, MD, Si
More informationSupplement materials:
Supplement materials: Table S1: ICD-9 codes used to define prevalent comorbid conditions and incident conditions Comorbid condition ICD-9 code Hypertension 401-405 Diabetes mellitus 250.x Myocardial infarction
More informationAnalysis of Mortality Within the First Six Months After Coronary Reoperation
Analysis of Mortality Within the First Six Months After Coronary Reoperation Frans M. van Eck, MD, Luc Noyez, MD, PhD, Freek W. A. Verheugt, MD, PhD, and Rene M. H. J. Brouwer, MD, PhD Departments of Thoracic
More informationTechnical Appendix for Outcome Measures
Study Overview Technical Appendix for Outcome Measures This is a report on data used, and analyses done, by MPA Healthcare Solutions (MPA, formerly Michael Pine and Associates) for Consumers CHECKBOOK/Center
More informationBicuspid aortic root spared during ascending aorta surgery: an update of long-term results
Short Communication Bicuspid aortic root spared during ascending aorta surgery: an update of long-term results Marco Russo, Guglielmo Saitto, Paolo Nardi, Fabio Bertoldo, Carlo Bassano, Antonio Scafuri,
More informationImportance of the third arterial graft in multiple arterial grafting strategies
Research Highlight Importance of the third arterial graft in multiple arterial grafting strategies David Glineur Department of Cardiovascular Surgery, Cliniques St Luc, Bouge and the Department of Cardiovascular
More informationSupplementary Online Content
1 Supplementary Online Content Friedman DJ, Piccini JP, Wang T, et al. Association between left atrial appendage occlusion and readmission for thromboembolism among patients with atrial fibrillation undergoing
More informationDoes the Presence of Preoperative Mild or Moderate Coronary Artery Disease Affect the Outcomes of Lung Transplantation?
Does the Presence of Preoperative Mild or Moderate Coronary Artery Disease Affect the Outcomes of Lung Transplantation? Cliff K. Choong, FRACS, Bryan F. Meyers, MD, Tracey J. Guthrie, BSN, Elbert P. Trulock,
More informationThe MAIN-COMPARE Registry
Long-Term Outcomes of Coronary Stent Implantation versus Bypass Surgery for the Treatment of Unprotected Left Main Coronary Artery Disease Revascularization for Unprotected Left MAIN Coronary Artery Stenosis:
More informationCLINICAL COMMUNIQUE 16 YEAR RESULTS
CLINICAL COMMUNIQUE 6 YEAR RESULTS Carpentier-Edwards PERIMOUNT Mitral Pericardial Bioprosthesis, Model 6900 Introduction The Carpentier-Edwards PERIMOUNT Mitral Pericardial Valve, Model 6900, was introduced
More informationPreoperative Anemia versus Blood Transfusion: Which is the Culprit for Worse Outcomes in Cardiac Surgery?
Preoperative Anemia versus Blood Transfusion: Which is the Culprit for Worse Outcomes in Cardiac Surgery? Damien J. LaPar MD, MSc, James M. Isbell MD, MSCI, Jeffrey B. Rich MD, Alan M. Speir MD, Mohammed
More informationChapter 9: Cardiovascular Disease in Patients With ESRD
Chapter 9: Cardiovascular Disease in Patients With ESRD Cardiovascular disease is common in adult ESRD patients, with atherosclerotic heart disease and congestive heart failure being the most common conditions
More informationDisclosures The PREVENT IV Trial was supported by Corgentech and Bristol-Myers Squibb
Saphenous Vein Grafts with Multiple Versus Single Distal Targets in Patients Undergoing Coronary Artery Bypass Surgery: One-Year Graft Failure and Five-Year Outcomes from the Project of Ex-vivo Vein Graft
More informationSafety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD
Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD Mun K. Hong, MD Associate Professor of Medicine Director, Cardiovascular Intervention and Research Weill Cornell
More informationCardiac surgery in Victorian public hospitals, Public report
Cardiac surgery in Victorian public hospitals, 2009 10 Public report Cardiac surgery in Victorian public hospitals, 2009 10 Public report Authors: DT Dinh, L Tran, V Chand, A Newcomb, G Shardey, B Billah
More informationContemporary outcomes for surgical mitral valve repair: A benchmark for evaluating emerging mitral valve technology
Contemporary outcomes for surgical mitral valve repair: A benchmark for evaluating emerging mitral valve technology Damien J. LaPar, MD, MSc, Daniel P. Mulloy, MD, Ivan K. Crosby, MBBS, D. Scott Lim, MD,
More informationMeasure #167 (NQF 0114): Coronary Artery Bypass Graft (CABG): Postoperative Renal Failure National Quality Strategy Domain: Effective Clinical Care
Measure #167 (NQF 0114): Coronary Artery Bypass Graft (CABG): Postoperative Renal Failure National Quality Strategy Domain: Effective Clinical Care 2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE
More informationSupplementary Online Content
Supplementary Online Content Leibowitz M, Karpati T, Cohen-Stavi CJ, et al. Association between achieved low-density lipoprotein levels and major adverse cardiac events in patients with stable ischemic
More informationOutcome of elderly patients with severe but asymptomatic aortic stenosis
Outcome of elderly patients with severe but asymptomatic aortic stenosis Robert Zilberszac, Harald Gabriel, Gerald Maurer, Raphael Rosenhek Department of Cardiology Medical University of Vienna ESC Congress
More informationWhy is co-morbidity important for cancer patients? Michael Chapman Research Programme Manager
Why is co-morbidity important for cancer patients? Michael Chapman Research Programme Manager Co-morbidity in cancer Definition:- Co-morbidity is a disease or illness affecting a cancer patient in addition
More informationDiabetes mellitus is an established risk factor for the
Influence of Diabetes on Mortality and Morbidity: Off-Pump Coronary Artery Bypass Grafting Versus Coronary Artery Bypass Grafting With Cardiopulmonary Bypass Mitchell J. Magee, MD, Todd M. Dewey, MD, Tea
More informationSurgical AVR: Are there any contraindications? Pyowon Park Samsung Medical Center Seoul, Korea
Surgical AVR: Are there any contraindications? Pyowon Park Samsung Medical Center Seoul, Korea Contents Decision making in surgical AVR in old age Clinical results of AVR with tissue valve Impact of 19mm
More informationThe importance of follow-up after a cardiac event: CARDIAC REHABILITATION. Dr. Guy Letcher
The importance of follow-up after a cardiac event: CARDIAC REHABILITATION Dr. Guy Letcher The National Medicare Experience Mortality After Angioplasty 225,915 patients Mortality After Bypass Surgery 357,885
More informationUSRDS UNITED STATES RENAL DATA SYSTEM
USRDS UNITED STATES RENAL DATA SYSTEM Chapter 9: Cardiovascular Disease in Patients With ESRD Cardiovascular disease is common in ESRD patients, with atherosclerotic heart disease and congestive heart
More informationIndications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014
Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014 Indications for cardiac catheterization Before a decision to perform an invasive procedure such
More information7. Literaturverzeichnis
Seite 60 7. Literaturverzeichnis 1. Grossmann R, Jr., Glunz HG, Seybold-Epting W, Albert FW: Invasive kardiologische Diagnostik und herzchirurgische Therapie bei Patienten mit terminaler Niereninsuffizienz,
More information16 YEAR RESULTS Carpentier-Edwards PERIMOUNT Mitral Pericardial Bioprosthesis, Model 6900
CLINICAL COMMUNIQUé 6 YEAR RESULTS Carpentier-Edwards PERIMOUNT Mitral Pericardial Bioprosthesis, Model 69 The Carpentier-Edwards PERIMOUNT Mitral Pericardial Valve, Model 69, was introduced into clinical
More informationAMERICAN SOCIETY OF ANESTHESIOLOGISTS ANESTHESIA PRE OPERATIVE SCREENING ASA PHYSICAL STATUS CLASSIFICATION ANESTHESIOLOGISTS
ANESTHESIA PRE OPERATIVE SCREENING CAPA S 37 TH ANNUAL CONFERENCE PALM SPRINGS OCTOBER 5, 2013 ROBERT F. KOPEL, MD, FACP, FCCP HOAG HOSPITAL ASSISTANT CLINICAL PROFESSOR UCLA SCHOOL OF MEDICINE AMERICAN
More informationImpaired Chronotropic Response to Exercise Stress Testing in Patients with Diabetes Predicts Future Cardiovascular Events
Diabetes Care Publish Ahead of Print, published online May 28, 2008 Chronotropic response in patients with diabetes Impaired Chronotropic Response to Exercise Stress Testing in Patients with Diabetes Predicts
More informationChairman and O. Wayne Isom Professor Department of Cardiothoracic Surgery Weill Cornell Medicine
Leonard N. Girardi, M.D. Chairman and O. Wayne Isom Professor Department of Cardiothoracic Surgery Weill Cornell Medicine New York, New York Houston Aortic Symposium Houston, Texas February 23, 2017 weill.cornell.edu
More informationRemodeling of the Remnant Aorta after Acute Type A Aortic Dissection Surgery
Remodeling of the Remnant Aorta after Acute Type A Aortic Dissection Surgery Are Young Patients More Likely to Develop Adverse Aortic Remodeling of the Remnant Aorta Over Time? Suk Jung Choo¹, Jihoon Kim¹,
More informationFEV1 predicts length of stay and in-hospital mortality in patients undergoing cardiac surgery
EUROPEAN SOCIETY OF CARDIOLOGY CONGRESS 2010 FEV1 predicts length of stay and in-hospital mortality in patients undergoing cardiac surgery Nicholas L Mills, David A McAllister, Sarah Wild, John D MacLay,
More informationOPCAB IS NOT BETTER THAN CONVENTIONAL CABG
OPCAB IS NOT BETTER THAN CONVENTIONAL CABG Harold L. Lazar, M.D. Harold L. Lazar, M.D. Professor of Cardiothoracic Surgery Boston Medical Center and the Boston University School of Medicine Boston, MA
More informationProcess Measure: Screening for Adult Obstructive Sleep Apnea
Process Measure: Screening for Adult Obstructive Sleep Apnea Measure Description Description Type of Measure All patients aged 18 years and older at high risk for obstructive sleep apnea (OSA) with documentation
More informationCORONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP OVERVIEW
CONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP OVERVIEW 2015 PQRS OPTIONS F MEASURES GROUPS: 2015 PQRS MEASURES IN CONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP: #43 Coronary Artery Bypass Graft (CABG):
More informationEACTS Adult Cardiac Database
EACTS Adult Cardiac Database Quality Improvement Programme List of changes to Version 2.0, 13 th Dec 2018, compared to version 1.0, 1 st May 2014. INTRODUCTORY NOTES This document s purpose is to list
More informationCABG in the Post-Aprotinin Era: Are We Doing Better? Ziv Beckerman, David Kadosh, Zvi Peled, Keren Bitton-Worms, Oved Cohen and Gil Bolotin
CABG in the Post-Aprotinin Era: Are We Doing Better? Ziv Beckerman, David Kadosh, Zvi Peled, Keren Bitton-Worms, Oved Cohen and Gil Bolotin DISCLOSURES None Objective(s): Our department routinely used
More information2008 Dialysis Facility Report
iii Purpose of the Report Enclosed is the (DFR) for this facility, based on data from the Centers for Medicare & Medicaid Services (CMS). This DFR includes data specific to provider number(s): 102844 These
More informationWhat is the Role of Surgical Repair in 2012
What is the Role of Surgical Repair in 2012 The Long-Term Results of Surgery Raphael Rosenhek Department of Cardiology Medical University of Vienna European Society of Cardiology 2012 Munich, August 27th
More informationCatheter-based mitral valve repair MitraClip System
Percutaneous Mitral Valve Repair: Results of the EVEREST II Trial William A. Gray MD Director of Endovascular Services Associate Professor of Clinical Medicine Columbia University Medical Center The Cardiovascular
More informationRevascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease
Impact of Angiographic Complete Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease Young-Hak Kim, Duk-Woo Park, Jong-Young Lee, Won-Jang
More informationMeasure #164 (NQF 0129): Coronary Artery Bypass Graft (CABG): Prolonged Intubation National Quality Strategy Domain: Effective Clinical Care
Measure #164 (NQF 0129): Coronary Artery Bypass Graft (CABG): Prolonged Intubation National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY DESCRIPTION:
More informationCoronary Artery Bypass Surgery in the Septuagenarian
Coronary Artery Bypass Surgery in the Septuagenarian Jerry B. Gooch, M.D., H. Edward Garrett, M.D., J.T. Davis, Jr., M.D., and Robert L. Richardson, M.D. Analyzed during a 3 -year period wvere 86 patientsfrom
More informationCoronary Artery Bypass Grafting in Diabetics: All Arterial or Hybrid?
Coronary Artery Bypass Grafting in Diabetics: All Arterial or Hybrid? Dr. Daniel Navia M.D. Chief Cardiac Surgery Department ICBA, Buenos Aires Argentina, 2018 No disclosures 2 Current evidence The FREEDOM
More informationThe operative mortality rate after redo valvular operations
Clinical Outcomes of Redo Valvular Operations: A 20-Year Experience Naoto Fukunaga, MD, Yukikatsu Okada, MD, Yasunobu Konishi, MD, Takashi Murashita, MD, Mitsuru Yuzaki, MD, Yu Shomura, MD, Hiroshi Fujiwara,
More information2011 Dialysis Facility Report
Purpose of the Report 2011 Dialysis Facility Report Enclosed is the 2011 Dialysis Facility Report (DFR) for your facility, based on data from the Centers for Medicare & Medicaid Services (CMS). This DFR
More information8/28/2018. Pre-op Evaluation for non cardiac surgery. A quick review from 2007!! Disclosures. John Steuter, MD. None
Pre-op Evaluation for non cardiac surgery John Steuter, MD Disclosures None A quick review from 2007!! Fliesheret al, ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and are for Noncardiac
More informationPredictive Ability of Novel Cardiac Biomarkers ST2, Galectin-3, and NT-ProBNP Before Cardiac Surgery
Predictive Ability of Novel Cardiac Biomarkers ST2, Galectin-3, and NT- Before Cardiac Surgery Sai Polineni, MPH; Devin M. Parker, MS; Shama S. Alam, PhD, MSc; Heather Thiessen-Philbrook, BMath, MMath;
More informationPredicting Short Term Morbidity following Revision Hip and Knee Arthroplasty
Predicting Short Term Morbidity following Revision Hip and Knee Arthroplasty A Review of ACS-NSQIP 2006-2012 Arjun Sebastian, M.D., Stephanie Polites, M.D., Kristine Thomsen, B.S., Elizabeth Habermann,
More informationChapter 4: Cardiovascular Disease in Patients With CKD
Chapter 4: Cardiovascular Disease in Patients With CKD Introduction Cardiovascular disease is an important comorbidity for patients with chronic kidney disease (CKD). CKD patients are at high-risk for
More informationSafety of Same-Day Coronary Angiography in Patients Undergoing Elective Aortic Valve Replacement
Safety of Same-Day Coronary Angiography in Patients Undergoing Elective Aortic Valve Replacement Kevin L. Greason, MD, Lars Englberger, MD, Rakesh M. Suri, MD, PhD, Soon J. Park, MD, Charanjit S. Rihal,
More informationThe Influence of Previous Percutaneous Coronary Intervention in Patients Undergoing Off-Pump Coronary Artery Bypass Grafting
Original Article The Influence of Previous Percutaneous Coronary Intervention in Patients Undergoing Off-Pump Coronary Artery Bypass Grafting Toshihiro Fukui, MD, Susumu Manabe, MD, Tomoki Shimokawa, MD,
More informationPreoperative Serum Bicarbonate Levels Predict Acute Kidney Iinjry after Cardiac Surgery
International Journal of ChemTech Research CODEN (USA): IJCRGG, ISSN: 0974-4290, ISSN(Online):2455-9555 Vol.11 No.06, pp 203-208, 2018 Preoperative Serum Bicarbonate Levels Predict Acute Kidney Iinjry
More informationA Novel Score to Estimate the Risk of Pneumonia After Cardiac Surgery
A Novel Score to Estimate the Risk of Pneumonia After Cardiac Surgery Arman Kilic, MD 1, Rika Ohkuma, MD 1, J. Trent Magruder, MD 1, Joshua C. Grimm, MD 1, Marc Sussman, MD 1, Eric B. Schneider, PhD 1,
More informationOutcomes of Surgical Aortic Valve Replacement in Moderate Risk Patients: Implications for Determination of Equipoise in the Transcatheter Era
Outcomes of Surgical Aortic Valve Replacement in Moderate Risk Patients: Implications for Determination of Equipoise in the Transcatheter Era Sebastian A. Iturra, Rakesh M. Suri, Kevin L. Greason, John
More informationTransfusion & Mortality. Philippe Van der Linden MD, PhD
Transfusion & Mortality Philippe Van der Linden MD, PhD Conflict of Interest Disclosure In the past 5 years, I have received honoraria or travel support for consulting or lecturing from the following companies:
More informationFY 2011 WISEWOMAN Approved ICD-9 Code List
243 Congenital hypothyroidism 245.0 Thyroiditis; Acute thyroiditis 245.1 Thyroiditis; Subacute thyroiditis 245.2 Thyroiditis; Chronic lymphocytic thyroiditis 245.3 Thyroiditis; Chronic fibrous thyroiditis
More informationManaging Hypertension in the Perioperative Arena
Managing Hypertension in the Perioperative Arena Optimizing Perioperative Management Strategies for Hypertension in the Cardiac Surgical Patient Objectives: Treatment of hypertensive emergencies. ALBERT
More informationComorbidity or medical history Existing diagnoses between 1 January 2007 and 31 December 2011 AF management care AF symptoms Tachycardia
Supplementary Table S1 International Classification of Disease 10 (ICD-10) codes Comorbidity or medical history Existing diagnoses between 1 January 2007 and 31 December 2011 AF management care I48 AF
More informationSurgical Outcomes: A synopsis & commentary on the Cardiac Care Quality Indicators Report. May 2018
Surgical Outcomes: A synopsis & commentary on the Cardiac Care Quality Indicators Report May 2018 Prepared by the Canadian Cardiovascular Society (CCS)/Canadian Society of Cardiac Surgeons (CSCS) Cardiac
More informationWhy is co-morbidity important for cancer patients? Di Riley Associate Director Clinical Outcomes Programme
Why is co-morbidity important for cancer patients? Di Riley Associate Director Clinical Outcomes Programme Co-morbidity in cancer Definition:- Co-morbidity is a disease or illness affecting a cancer patient
More informationProper Completion of a Death Certificate"
Proper Completion of a Death Certificate" Pennsylvania Department of Health Bureau of Health Statistics and Research Division of Statistical Registries Division of Vital Records Why should you care? 1.
More informationData Fact Sheet. Congestive Heart Failure in the United States: A New Epidemic
National Heart, Lung, and Blood Institute Data Fact Sheet Congestive Heart Failure National Heart, Lung, and Blood Institute National Institutes of Health Data Fact Sheet Congestive Heart Failure in the
More information2011 Dialysis Facility Report SAMPLE Dialysis Facility State: XX Network: 99 CCN: SAMPLE Dialysis Facility Report SAMPLE
Purpose of the Report Enclosed is the (DFR) for your facility, based on data from the Centers for Medicare & Medicaid Services (CMS). This DFR includes data specific to CCN(s): 999999 These data could
More informationPreoperative tests (update)
National Institute for Health and Care Excellence. Preoperative tests (update) Routine preoperative tests for elective surgery NICE guideline NG45 Appendix N: Research recommendations April 2016 Developed
More informationIn the United States, 97 million overweight or obese
The Risks of Moderate and Extreme Obesity for Coronary Artery Bypass Grafting Outcomes: A Study From The Society of Thoracic Surgeons Database Ganga Prabhakar, MD, Constance K. Haan, MD, Eric D. Peterson,
More informationTicagrelor compared with clopidogrel in patients with acute coronary syndromes the PLATO trial
compared with clopidogrel in patients with acute coronary syndromes the PLATO trial August 30, 2009 at 08.00 CET PLATO background In NSTE-ACS and STEMI, current guidelines recommend 12 months aspirin and
More informationMitral Valve Repair Does Hospital Volume Matter? Juan P. Umaña, M.D. Chief Medical Officer FCI Institute of Cardiology Bogotá Colombia
Mitral Valve Repair Does Hospital Volume Matter? Juan P. Umaña, M.D. Chief Medical Officer FCI Institute of Cardiology Bogotá Colombia Disclosures Edwards Lifesciences Consultant Abbott Mitraclip Royalties
More informationFFR and CABG Emanuele Barbato, MD, PhD, FESC Cardiovascular Center Aalst, Belgium
FFR and CABG Emanuele Barbato, MD, PhD, FESC Cardiovascular Center Aalst, Belgium Conflict of Interest Institutional research grants and speaker s fee from St. Jude Medical and Boston Scientic to Cardiovascular
More informationThe clinical trial information provided in this public disclosure synopsis is supplied for informational purposes only.
The clinical trial information provided in this public disclosure synopsis is supplied for informational purposes only. Please note that the results reported in any single trial may not reflect the overall
More informationIschemic Heart Disease Interventional Treatment
Ischemic Heart Disease Interventional Treatment Cardiac Catheterization Laboratory Procedures (N = 89) is a regional and national referral center for percutaneous coronary intervention (PCI). A total of
More informationAPPENDIX EXHIBITS. Appendix Exhibit A2: Patient Comorbidity Codes Used To Risk- Standardize Hospital Mortality and Readmission Rates page 10
Ross JS, Bernheim SM, Lin Z, Drye EE, Chen J, Normand ST, et al. Based on key measures, care quality for Medicare enrollees at safety-net and non-safety-net hospitals was almost equal. Health Aff (Millwood).
More informationComplex Thoracic and Abdominal Aortic Repair Using Hybrid Techniques
Complex Thoracic and Abdominal Aortic Repair Using Hybrid Techniques Tariq Almerey MD, January Moore BA, Houssam Farres MD, Richard Agnew MD, W. Andrew Oldenburg MD, Albert Hakaim MD Department of Vascular
More informationEarly readmission for congestive heart failure predicts late mortality after cardiac surgery
Lee et al Perioperative Management Early readmission for congestive heart failure predicts late mortality after cardiac surgery Richard Lee, MD, MBA, Natalie Homer, BS, Adin-Cristian Andrei, PhD, Edwin
More informationChanging profile of patients undergoing redo-coronary artery surgery q
European Journal of Cardio-thoracic Surgery 21 (2002) 205 211 www.elsevier.com/locate/ejcts Changing profile of patients undergoing redo-coronary artery surgery q Frans M. van Eck, Luc Noyez*, Freek W.A.
More informationDoes preoperative atrial fibrillation increase the risk for mortality and morbidity after coronary artery bypass grafting?
Ad et al Acquired Cardiovascular Disease Does preoperative atrial fibrillation increase the risk for mortality and morbidity after coronary artery bypass grafting? Niv Ad, MD, a Scott D. Barnett, PhD,
More informationEuroSCORE Predicts Short- and Mid-Term Mortality in Combined Aortic Valve Replacement and Coronary Artery Bypass Patients
c 2009 Wiley Periodicals, Inc. 637 EuroSCORE Predicts Short- and Mid-Term Mortality in Combined Aortic Valve Replacement and Coronary Artery Bypass Patients Kimiyoshi J. Kobayashi, B.S., Jason A. Williams,
More informationStatistical Fact Sheet Populations
Statistical Fact Sheet Populations At-a-Glance Summary Tables Men and Cardiovascular Diseases Mexican- American Males Diseases and Risk Factors Total Population Total Males White Males Black Males Total
More informationAtrial Fibrillation Correction Surgery: Lessons From The Society of Thoracic Surgeons National Cardiac Database
Atrial Fibrillation Correction Surgery: Lessons From The Society of Thoracic Surgeons National Cardiac Database James S. Gammie, MD, Michel Haddad, MD, Sarah Milford-Beland, MS, Karl F. Welke, MD, T. Bruce
More informationDUKECATHR Dataset Dictionary
DUKECATHR Dataset Dictionary Version of DUKECATH dataset for educational use that has been modified to be unsuitable for clinical research or publication (Created Date and Time: 28OCT16 14:35) Table of
More informationThe Prognostic Importance of Comorbidity for Mortality in Patients With Stable Coronary Artery Disease
Journal of the American College of Cardiology Vol. 43, No. 4, 2004 2004 by the American College of Cardiology Foundation ISSN 0735-1097/04/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2003.10.031
More informationSurgical Consensus Standards Endorsement Maintenance NQF-Endorsed Surgical Maintenance Standards (Phase I) Table of Contents
Table of Contents #0113: Participation in a Systematic Database for Cardiac Surgery... 2 #0114: Post-operative Renal Failure... 2 #0115: Surgical Re-exploration... 3 #0116: Anti-Platelet Medication at
More informationOff-Pump Cardiac Surgery is not Dead
Off-Pump Cardiac Surgery is not Dead Gonzalo J. Carrizo, M.D. Fellow Cardiothoracic Surgery Division Cardiothoracic Surgery Department of Surgery University of Colorado Hopeman Lectureship September 10,2007
More informationIs laparoscopic sleeve gastrectomy safer than laparoscopic gastric bypass?
Is laparoscopic sleeve gastrectomy safer than laparoscopic gastric bypass? A comparison of 30-day complications using the MBSAQIP data registry Sandhya B. Kumar MD, Barbara C. Hamilton MD, Soren Jonzzon,
More informationAppendix 1: Supplementary tables [posted as supplied by author]
Appendix 1: Supplementary tables [posted as supplied by author] Table A. International Classification of Diseases, Ninth Revision, Clinical Modification Codes Used to Define Heart Failure, Acute Myocardial
More informationInformation for patients (and their families) waiting for liver transplantation
Information for patients (and their families) waiting for liver transplantation Waiting list? What is liver transplant? Postoperative conditions? Ver.: 5/2017 1 What is a liver transplant? Liver transplantation
More informationPresenter Disclosure. Patrick O. Myers, M.D. No Relationships to Disclose
Presenter Disclosure Patrick O. Myers, M.D. No Relationships to Disclose Aortic Valve Repair by Cusp Extension for Rheumatic Aortic Insufficiency in Children Long term Results and Impact of Extension Material
More informationRandomized comparison of single versus double mammary coronary artery bypass grafting: 5 year outcomes of the Arterial Revascularization Trial
Randomized comparison of single versus double mammary coronary artery bypass grafting: 5 year outcomes of the Arterial Revascularization Trial Embargoed until 10:45 a.m. CT, Monday, Nov. 14, 2016 David
More informationPreoperative Cardiac Evaluation of Patients With Acute Hip Fracture
An Original Study Preoperative Cardiac Evaluation of Patients With Acute Hip Fracture Jonathan Cluett, MD, Jill Caplan, MD, and Warren Yu, MD Abstract The goals of the present study were to assess if there
More informationMitral Gradients and Frequency of Recurrence of Mitral Regurgitation After Ring Annuloplasty for Ischemic Mitral Regurgitation
Mitral Gradients and Frequency of Recurrence of Mitral Regurgitation After Ring Annuloplasty for Ischemic Mitral Regurgitation Matthew L. Williams, MD, Mani A. Daneshmand, MD, James G. Jollis, MD, John
More information6 GERIATRIC CARDIAC SURGERY
6 GERIATRIC CARDIAC SURGERY Nicola Francalancia, MD; Joseph LoCicero III, MD, FACS* Cardiovascular disease is the leading cause of death in the United States; 84% of deaths from cardiovascular disease
More informationSupplemental Table 1. Standardized Serum Creatinine Measurements. Supplemental Table 3. Sensitivity Analyses with Additional Mortality Outcomes.
SUPPLEMENTAL MATERIAL Supplemental Table 1. Standardized Serum Creatinine Measurements Supplemental Table 2. List of ICD 9 and ICD 10 Billing Codes Supplemental Table 3. Sensitivity Analyses with Additional
More informationEPO-144 Patients with Morbid Obesity and Congestive Heart Failure Have Longer Operative Time and Room Time in Total Hip Arthroplasty
SESUG 2016 EPO-144 Patients with Morbid Obesity and Congestive Heart Failure Have Longer Operative Time and Room Time in Total Hip Arthroplasty ABSTRACT Yubo Gao, University of Iowa Hospitals and Clinics,
More informationUniversity of Florida Department of Surgery. CardioThoracic Surgery VA Learning Objectives
University of Florida Department of Surgery CardioThoracic Surgery VA Learning Objectives This service performs coronary revascularization, valve replacement and lung cancer resections. There are 2 faculty
More information